“We’re working hard on developing the Merah Putih vaccine, but we hope all layers of society won’t expect too much — thinking that we already have the vaccines so we can loosen [health protocols] and that all the problem will end with a vaccine,” said Amin Soebandrio from the Eijkman Institute for Molecular Biology.Indonesia’s Merah Putih candidate vaccine, named after the colors of the national flag, has yet to enter the pre-clinical phase and is not expected for mass production by Bio Farma until 2022.Read also: What you need to know about Indonesia’s vaccine developmentAmin said that even with vaccines ready for public use, it did not mean the “virus would be gone” because the process to build immunity among those vaccinated, who in turn will protect those yet to be or not vaccinated, would be gradual rather than instant.”We want to achieve the so-called true herd immunity, which is developed through vaccination,” he said. “Indonesia has a large population. If [the threshold of vaccination coverage was to reach] 70 percent, then we’d have to vaccinate some  million people; and we couldn’t possibly get to everyone in a week or two.”Achieving herd immunity would not only protect those vaccinated, but also immunocompromised individuals and those not yet vaccinated, hence preventing outbreaks.Bio Farma’s research and development project integration manager Neni Nurainy said that how far vaccines could protect the people would depend on their eventual efficacy, and whether people could possibly go back to their normal pre-pandemic life would also depend on the vaccination coverage to achieve the desired herd immunity.According to the World Health Organization, no vaccine is 100 percent effective — most routine childhood vaccines are effective for 85 to 95 percent of recipients and not all vaccinated persons develop immunity for a variety of individual reasons.In another vaccine-making scheme, Bio Farma has partnered with China’s Sinovac Biotech to roll out the last phase of clinical trials on humans for Sinovac’s potential vaccine, and if it proves effective, it expects to produce 40 million doses in the first stage.”In order for people to remain productive, people in the seven hardest-hit regions will be vaccinated first; Jakarta, Surabaya, Semarang, Yogyakarta, Bandung; big cities where the case numbers are high. So not all provinces will be given [the vaccine at first],” clinical trial research team leader and Padjadjaran University professor Kusnandi Rusmil said.Read also: Wanted: Volunteers for first human trial of COVID-19 vaccine in IndonesiaThe high hopes for vaccines are justified, epidemiologist at Airlangga University Laura Navika Yamani said, but there was always the possibility of candidate vaccines failing, such as with HIV, or not working as well as expected.A working vaccine, she said, typically also needed further studies to find out whether the antibodies formed would remain strong enough or wane as time passed, and, therefore, require booster doses.”Vaccines do bring hope, but it shouldn’t be the only hope. Don’t be too transfixed on vaccines so that if they fail, we’ll be too disappointed […] There are many other efforts we can make to contain COVID-19,” she said.Another concern was the vaccination coverage rate needed to reach herd immunity, which varied according to viruses’ characteristics, such as their reproduction number, Laura said.She said that even with existing vaccines, Indonesia faced difficulties reaching the threshold, for several reasons, such as the vast geographical distances between regions, poor logistics, misinformation and antivaccine stances fueled by religious concerns over the vaccines’ ingredients.Production capacity of COVID-19 vaccines to meet the needs of all Indonesians is also a concern, hence authorities should communicate early to the public about any prioritized target groups, such as younger people who could produce antibodies better than the elderly, to prevent social jealousy, Laura said.”What we want is to develop immunity through vaccination, not through natural infection. One of the ways to end the pandemic is to have people infected naturally, but if we let this go on now there’ll be victimized groups. Susceptible groups will die,” she said. “With the COVID-19 mortality rate in Indonesia and globally now at around 4 percent, are we ready for that?”Topics : COVID-19 cases and deaths, meanwhile, continue to soar. The government reported 1,882 new cases and 69 new deaths on Thursday, pushing the national tally to 118,753 confirmed cases — including 43,108 active cases — and 5,521 fatalities.Government officials have nevertheless echoed Jokowi’s sentiment. State-Owned Enterprises (SOEs) Minister Erick Thohir, who also helms the national economic and COVID-19 recovery committee, has claimed that state pharmaceutical holding company Bio Farma is ready to produce 250 million doses of a vaccine, although no vaccine has yet been approved for commercial use.Experts firmly believe that vaccines will be effective in arming the people to better fight the coronavirus that causes the COVID-19 disease, and thus help to contain the pandemic sooner, as they have done with many other diseases.However, many also believe that vaccines should not be seen as the only way out and that trials under way might fail. Even if they do succeed, experts say that the vaccines’ efficacy may vary and immunity developed by vaccines may not last forever, while it might also take some time to leverage the vaccination drive in Indonesia, the world’s largest archipelago of some 271 million people. The possible development of a vaccine has brought as much hope to Indonesia as it has to any other country battered by the COVID-19 pandemic.President Joko “Jokowi” Widodo said in late July that he expected that next year the Indonesian economy would be able to recover and that a vaccine would be discovered and mass vaccination for “all the people in the country” would be rolled out.Indonesia saw its GDP contract 5.32 percent in the second quarter of this year, the worst contraction since the 1998 Asian financial crisis, and unemployment haunts around 10 million people.
The home at 57 Kadumba St, Yeronga is on the marketA CHARACTER cottage with swimming pool is new to the market in Yeronga. Cate Spence bought the property at 57 Kadumba St 11 years ago after falling in love with the VJ walls, high ceilings and “beautiful” fretwork. “I just love old Queenslanders and homes with character,” she said. In the time she has owned the property, Ms Spence has renovated the bathrooms, removed a wall between the kitchen and lounge room, revamped the kitchen and repainted the home, all while retaining the heritage charm. The kitchen opens to the living area.“I also added a deck out the back and removed all the palm trees that were in the yard and replaced them with natives,” she said. More from newsCrowd expected as mega estate goes under the hammer7 Aug 2020Hard work, resourcefulness and $17k bring old Ipswich home back to life20 Apr 2020The four-bedroom cottage has polished timber floors, a front balcony and double lockup garage. The dine-in kitchen has bi-fold windows that open to the back deck and a storage area off the kitchen has been turned into a walk-in pantry. The lounge room has built-in bookcases and there is a dressing room off the master bedroom that could be converted into an ensuite. The back deck is shaded by native trees.Ms Spence is selling to relocate but she said she would miss her fabulous neighbours.“The house is in such a great area and it’s so close to the city,” she said. The home is being marketed by Sharon and Kate Wilson from McGrath Annerley Yeronga for offers over $735,000. The lounger room has built-in bookcasesDownstairs is a self-contained area with a bedroom, which needs council approval, a living area, kitchenette and bathroom. Outside, the yard is fully enclosed and there is a fenced, above-ground pool. Ms Spence said her favourite space inside the home was the open living area and kitchen while the deck was her “go to place” in the summer. “It’s very private because of the beautiful trees, and it faces north, so it gets lots of lovely breezes,” she said.
AN unwavering Australia wrapped up a decisive fifth Test victory at the SCG and 4-0 series triumph on an Ashes finale overshadowed by an illness to stricken England captain Joe Root.In a dramatic ending to a somewhat underwhelming series, Root struggled with a viral gastroenteritis bug forcing him to be able to bat only for an hour yesterday.He added 16 runs to his overnight score of 42 but was unable to resume batting after lunch.Without their ailing captain, England crumbled after lunch against a withering spell from dynamic Australian quick Pat Cummins, who claimed three quick wickets as Australia completed a dominant series with an innings and 123-run victory. England finished on 180 for 9 with Root retiring on 58 not out.In a fitting grim end to a nightmare Ashes tour for the hapless England, there was a dramatic start to the Ashes finale with Root not resuming his innings of 42 not out after being hospitalised with the bug.There were initial fears that Root had suffered from severe dehydration after being in the thick of oppressive conditions for much of Sunday with temperatures hitting 57.6 degrees in the middle of the SCG at one point.Amid stifling humidity, Root bravely came to the crease an hour into the day at the fall of Moeen Ali’s wicket and quickly notched his fifth half-century of the series. He battled hard alongside Jonny Bairstow to reach lunch 58 not out as England’s hopes of salvaging an unlikely draw increased slightly.However, an ill Root was unable to resume his innings after lunch and England’s chances quickly nosedived with Cummins, arguably Australia’s best quick of the series, ending Bairstow’s (38 from 143 balls) resistance with a piercing delivery that trapped the wicketkeeper lbw. Moments later, Cummins (4 for 39) bounced out Stuart Broad as England quickly plummeted to 148 for 7.Cummins, the team’s enforcer and emerging into Australia’s best quick, then repeated the dose by dismissing Mason Crane with a brute of a short ball as Australia stormed to their ninth victory from their past two home Ashes series.England started in a perilous position at 93 for 4 still trailing by 210 runs and without their captain at the crease.With Root ailed, struggling all-rounder Moeen came out to bat with Bairstow and the pair shed their attacking instincts to defend gamely against probing Australian bowling. With Root stricken, the prevailing belief was that the embattled tourists would roll over but Bairstow and Moeen offered dogged fight on a pitch showing little wear although off-spinner Nathan Lyon relished extracting menacing turn.There were no chances for almost an hour until Moeen (13) was trapped by his tormentor Lyon on the stroke of the drinks break. It was the seventh time in the series Lyon dismissed Moeen, who finished a horrendous series with a miserable average of 20.Despite every Test going into the fifth day for the first time in the Ashes since 1994-95, it was a lopsided series with none of the matches going down to the wire in thrilling fashion. Quite fittingly for a lack-lustre contest, the Ashes finale at the SCG inevitably fizzled out to finish a one-sided Test and series.After a convincing Ashes triumph, Australia will be celebrating long into the night having stunningly regained the urn. Conversely, an embattled England are set to feel the heat after a highly disappointing campaign ended in another embarrassment Down Under. (Cricbuzz.com)ENGLAND 1st innings (346)ENGLAND 1st innings (346)Australia 1st innings 649 for 7 declared England 2nd innings (overnight) 93-4A. Cook b Lyon 10M. Stoneman lbw b Starc 0J. Vince c Smith b Cummins 18J. Root (c) retired hurt 58D. Malan lbw b Lyon 5J. Bairstow † lbw b Cummins 38M. Ali lbw b Lyon 13T. Curran not out 23S. Broad c †Paine b Cummins 4M. Crane c †Paine b Cummins 2J. Anderson c †Paine b Hazlewood 2Extras: (lb 2, pen 5) 7Total: (88.1 overs) 180 all outFall of wickets: 1-5, 2-15, 3-43, 4-68, 4-93, 5-121, 5-144, 6-144, 7-148, 8-156, 9-180Bowling: M. Starc 16-4-38-1, J. Hazlewood 17.1-6-36-1, N. Lyon 35-12-54-3, P. Cummins 17-4-39-4, S. Smith 2-0-6-0, M. Marsh 1-1-0-0